Mirinezhad et al., 2014 - Google Patents
Impact of tumor length on survival for patients with resected esophageal cancerMirinezhad et al., 2014
View PDF- Document ID
- 8766787473603388234
- Author
- Mirinezhad S
- Jangjoo A
- Seyednejad F
- Naseri A
- Mohammadzadeh M
- Nasiri B
- Eftekharsadat A
- Farhang S
- Somi M
- Publication year
- Publication venue
- Asian Pacific Journal of Cancer Prevention
External Links
Snippet
Background: Tumor length in patients with esophageal cancer (EC) has recently received great attention. However, its prognostic role for EC is controversial. The purpose of our study was to characterize the prognostic value of tumor length in EC patients and offer the …
- 206010028980 Neoplasm 0 title abstract description 105
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ye et al. | Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma | |
Hanagiri et al. | Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer | |
Dziedzic et al. | Risk factors for local and distant recurrence after surgical treatment in patients with non–small-cell lung cancer | |
Koike et al. | Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non–small-cell lung cancer patients | |
Lordick et al. | Multimodal treatment of esophageal cancer | |
Ilmer et al. | Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection | |
Wang et al. | Tumor length as a prognostic factor in esophageal squamous cell carcinoma | |
Urban et al. | Lymph node ratio may predict the benefit of postoperative radiotherapy in non–small-cell lung cancer | |
Barbour et al. | Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors | |
Mirinezhad et al. | Impact of tumor length on survival for patients with resected esophageal cancer | |
Biondi et al. | Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? | |
Watanabe et al. | Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis | |
Seok et al. | Frequency of lymph node metastasis according to the size of tumors in resected pulmonary adenocarcinoma with a size of 30 mm or smaller | |
Qiu et al. | The prognostic value of ratio-based lymph node staging in resected non–small-cell lung cancer | |
Shimura et al. | Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice | |
Miyata et al. | Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET) | |
Barbetta et al. | Neutrophil to lymphocyte ratio as predictor of treatment response in esophageal squamous cell cancer | |
Kunisaki et al. | Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma | |
Jan et al. | Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital | |
Shoji et al. | Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer | |
Hattori et al. | Oncological characteristics of radiological invasive adenocarcinoma with additional ground-glass nodules on initial thin-section computed tomography: comparison with solitary invasive adenocarcinoma | |
Wang et al. | Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology and their impact on the surgical strategy: analysis of single institutional experience | |
Kim et al. | Natural history of ground-glass nodules detected on the chest computed tomography scan after major lung resection | |
Greenberg et al. | Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection | |
Deng et al. | Surgical choice for clinical stage IA non-small cell lung cancer: view from regional lymph node metastasis |